Product Portfolio

The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.

Eye drops20 mg

DORZOLAMIDA ARENA 20 mg

Ophthalmic drug (carbonic anhydrase inhibitor), indicated in the treatment of glaucoma

Active Substance (INN)

DORZOLAMIDUM

Packaging

box x 1 bottle

Adverse Reaction Reporting

To report an adverse reaction, please contact us using the email address below and provide all relevant information.

informatii.medicale@arenagroup.ro

Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.